Page last updated: 2024-08-16

succinylcholine and labetalol

succinylcholine has been researched along with labetalol in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's1 (20.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Avramov, MN; Husain, MM; Stool, LA; White, PF1
Angel, JJ; Bush, AJ; Lawson, P; Ramanathan, J; Sibai, B1

Reviews

1 review(s) available for succinylcholine and labetalol

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Trials

1 trial(s) available for succinylcholine and labetalol

ArticleYear
Effects of nicardipine and labetalol on the acute hemodynamic response to electroconvulsive therapy.
    Journal of clinical anesthesia, 1998, Volume: 10, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Anesthetics, Intravenous; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Double-Blind Method; Drug Combinations; Electroconvulsive Therapy; Electroencephalography; Glycopyrrolate; Heart Rate; Humans; Infusions, Intravenous; Injections, Intravenous; Labetalol; Methohexital; Middle Aged; Muscarinic Antagonists; Neuromuscular Depolarizing Agents; Nicardipine; Placebos; Prospective Studies; Seizures; Succinylcholine

1998

Other Studies

3 other study(ies) available for succinylcholine and labetalol

ArticleYear
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
    Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3

    Topics:

2008
FDA-approved drug labeling for the study of drug-induced liver injury.
    Drug discovery today, 2011, Volume: 16, Issue:15-16

    Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration

2011
Changes in maternal middle cerebral artery blood flow velocity associated with general anesthesia in severe preeclampsia.
    Anesthesia and analgesia, 1999, Volume: 88, Issue:2

    Topics: Adult; Anesthesia, General; Anesthetics, Intravenous; Antihypertensive Agents; Blood Flow Velocity; Blood Pressure; Cerebral Arteries; Cerebrovascular Circulation; Cesarean Section; Female; Heart Rate; Humans; Injections, Intravenous; Intubation, Intratracheal; Labetalol; Neuromuscular Depolarizing Agents; Pre-Eclampsia; Pregnancy; Prospective Studies; Regression Analysis; Succinylcholine; Thiopental; Ultrasonography, Doppler, Transcranial

1999